ASHLEY BABINEAUX: Open Payments
NPI 1356021877 · LAKE CHARLES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,016 in 75 payments from 18 companies in 2025. Trend: 2023 $154 · 2024 $107 · 2025 $2,016
Food & beverage: $2,016
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $494 |
| Viatris Specialty LLC | 7 | $255 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $185 |
| Grifols USA, LLC | 8 | $179 |
| Regeneron Healthcare Solutions, Inc. | 3 | $170 |
| GlaxoSmithKline, LLC. | 7 | $145 |
| Merck Sharp & Dohme LLC | 6 | $119 |
| Verona Pharma, Inc. | 5 | $102 |
| Amgen Inc. | 4 | $72 |
| ANI Pharmaceuticals, Inc. | 2 | $67 |
Products named: TEZSPIRE, YUPELRI, DUPIXENT, Prolastin-C Liquid, NUCALA, FASENRA, Ohtuvayre, WINREVAIR.
Industry payments across LA — which companies pay providers there.
